Luspatercept for non‐deletional hemoglobin H disease

Documenti analoghi

• Evans syndrome in the background of 22q11.2 deletion syndrome
  di: Mohmmad M. Alawajneh, et al.
  Pubblicazione: (2024)
• Long‐term hematopoietic dysfunction in patients with large‐scale mitochondrial DNA deletion syndromes
  di: Noa Greenberg‐Kushnir, et al.
  Pubblicazione: (2024)
• Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome
  di: Atsushi Sakamoto, et al.
  Pubblicazione: (2024)
• Comment on: Severe β‐thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia—The deceivingly normal mean corpuscular volume and hemoglobin electrophoresis in dominantly inherited β‐thalassemia: Hb Little Venice
  di: Anselm Chi‐wai Lee, et al.
  Pubblicazione: (2024)
• Feasibility of 18 F‐DOPA and 18 F‐FDG PET/CT for guiding decision‐making for localized incidental neuroblastoma in infants under 18 months of age
  di: Wan‐Ting Hung, et al.
  Pubblicazione: (2024)